Citations (227)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Mustafa Alwani, Aksam Yassin, Raidh Talib, Ahmad Al-Qudimat, Omar Aboumarzouk, Raed M Al-Zoubi, Farid Saad, Karim S Haider & Abdulla Al Ansari. (2021) Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data. Vascular Health and Risk Management 17, pages 497-508.
Read now
Read now
Ahmed M. Bakr, Amro A. El-Sakka & Ahmed I. El-Sakka. (2021) Considerations for prescribing pharmacotherapy for the treatment of erectile dysfunction. Expert Opinion on Pharmacotherapy 22:7, pages 821-834.
Read now
Read now
Jeremy M Auerbach & Mohit Khera. (2020) Hypogonadism management and cardiovascular health. Postgraduate Medicine 132:sup4, pages 35-41.
Read now
Read now
A. Yassin, K. AlRumaihi, R. Alzubaidi, S. Alkadhi & A. Al Ansari. (2019) Testosterone, testosterone therapy and prostate cancer. The Aging Male 22:4, pages 219-227.
Read now
Read now
G Corona, G Rastrelli, F Guaraldi, G Tortorici, Y Reismann, A Sforza & M Maggi. (2019) An update on heart disease risk associated with testosterone boosting medications. Expert Opinion on Drug Safety 18:4, pages 321-332.
Read now
Read now
Evan Sehn, Cassidy Mozak, Nese Yuksel & Cheryl A. Sadowski. (2019) An analysis of online content related to testosterone supplementation. The Aging Male 22:2, pages 141-149.
Read now
Read now
Tom E. Nightingale, Pamela Moore, Joshua Harman, Refka Khalil, Ranjodh S. Gill, Teodoro Castillo, Robert A. Adler & Ashraf S. Gorgey. (2018) Body composition changes with testosterone replacement therapy following spinal cord injury and aging: A mini review. The Journal of Spinal Cord Medicine 41:6, pages 624-636.
Read now
Read now
Naoki Harada. (2018) Role of androgens in energy metabolism affecting on body composition, metabolic syndrome, type 2 diabetes, cardiovascular disease, and longevity: lessons from a meta-analysis and rodent studies. Bioscience, Biotechnology, and Biochemistry 82:10, pages 1667-1682.
Read now
Read now
Giulia Rastrelli, Mauro Dicuio, Yacov Reismann, Alessandra Sforza, Mario Maggi & Giovanni Corona. (2018) Cardiovascular impact of testosterone therapy for hypogonadism. Expert Review of Cardiovascular Therapy 16:9, pages 617-625.
Read now
Read now
G. Corona, G. Rastrelli, Y. Reisman, A. Sforza & M. Maggi. (2018) The safety of available treatments of male hypogonadism in organic and functional hypogonadism. Expert Opinion on Drug Safety 17:3, pages 277-292.
Read now
Read now
Maria Chiara Decaroli & Vincenzo Rochira. (2017) Aging and sex hormones in males. Virulence 8:5, pages 545-570.
Read now
Read now
Onder Canguven, Raidh A. Talib, Walid El Ansari, Dany-Jan Yassin & Abdullah Al Naimi. (2017) Vitamin D treatment improves levels of sexual hormones, metabolic parameters and erectile function in middle-aged vitamin D deficient men. The Aging Male 20:1, pages 9-16.
Read now
Read now
Ahmad Haider, Aksam Yassin, Karim Sultan Haider, Gheorghe Doros, Farid Saad & Giuseppe MC Rosano. (2016) Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study. Vascular Health and Risk Management 12, pages 251-261.
Read now
Read now
Alekhya Mascarenhas, Sobia Khan, Radha Sayal, Sandra Knowles, Tara Gomes & Julia E. Moore. (2016) Factors that may be influencing the rise in prescription testosterone replacement therapy in adult men: a qualitative study. The Aging Male 19:2, pages 90-95.
Read now
Read now
Chen-Hsun Ho, Chia-Chang Wu, Kuan-Chou Chen, Fu-Shan Jaw, Hong-Jeng Yu & Shih-Ping Liu. (2016) Erectile dysfunction, loss of libido and low sexual frequency increase the risk of cardiovascular disease in men with low testosterone. The Aging Male 19:2, pages 96-101.
Read now
Read now
Darryl P. Leong & Koon K. Teo. (2015) Predicting cardiovascular disease from handgrip strength: the potential clinical implications. Expert Review of Cardiovascular Therapy 13:12, pages 1277-1279.
Read now
Read now
Arthi Thirumalai, Katya B Rubinow & Stephanie T Page. (2015) An update on testosterone, HDL and cardiovascular risk in men. Clinical Lipidology 10:3, pages 251-258.
Read now
Read now
Bruno Lunenfeld, George Mskhalaya, Michael Zitzmann, Stefan Arver, Svetlana Kalinchenko, Yuliya Tishova & Abraham Morgentaler. (2015) Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men. The Aging Male 18:1, pages 5-15.
Read now
Read now
Giovanni Corona, Elisa Maseroli & Mario Maggi. (2014) Injectable testosterone undecanoate for the treatment of hypogonadism. Expert Opinion on Pharmacotherapy 15:13, pages 1903-1926.
Read now
Read now
Articles from other publishers (208)
Ahmed Sayed Mettawi. 2024. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
100
110
.
George A. Kanakis, Riccardo Pofi, Dimitrios G. Goulis, Andrea M. Isidori, Eleni Armeni, C. Tamer Erel, Ivan Fistonić, Timothy Hillard, Angelica-Lindén Hirschberg, Blazej Meczekalski, Nicolás Mendoza, Alfred O. Mueck, Tommaso Simoncini, Petra Stute, Dorenda van Dijken, Margaret Rees & Irene Lambrinoudaki. (2023) EMAS position statement: Testosterone replacement therapy in older men. Maturitas 178, pages 107854.
Crossref
Crossref
Anastasia V. Makarova, Sergey B. Shustov, Yuri S. Khalimov, Sergey V. Gaiduk, Viktor P. Kitsyshin & Dmitry S. Frolov. (2023) Testosterone, atherosclerosis and cardiovascular risks. Bulletin of the Russian Military Medical Academy 25:3, pages 481-491.
Crossref
Crossref
David Čapka. (2023) Cardiovascular safety of testosterone replacement therapy. Urologie pro praxi 24:3, pages 180-183.
Crossref
Crossref
Aayushi Sood, Alireza Hosseinpour, Akshit Sood, Sreekant Avula, Jawahar Durrani, Vishal Bhatia & Rahul Gupta. (2023) Cardiovascular Outcomes of Hypogonadal Men Receiving Testosterone Replacement Therapy: A Meta-analysis of Randomized Controlled Trials. Endocrine Practice.
Crossref
Crossref
David J Handelsman, Mathis Grossmann, Bu B Yeap, Bronwyn G A Stuckey, Nandini Shankara-Narayana, Ann J Conway, Warrick J Inder, Robert I McLachlan, Carolyn Allan, Alicia J Jenkins, David Jesudason, Karen Bracken & Gary A Wittert. (2023) Long-term Outcomes of Testosterone Treatment in Men: A T4DM Postrandomization Observational Follow-up Study. The Journal of Clinical Endocrinology & Metabolism.
Crossref
Crossref
Daniel J Green, Lauren C Chasland, Louise H Naylor & Bu B Yeap. (2023) New Horizons: Testosterone or Exercise for Cardiometabolic Health in Older Men. The Journal of Clinical Endocrinology & Metabolism 108:9, pages 2141-2153.
Crossref
Crossref
A. Michael LincoffShalender BhasinPanagiotis FlevarisLisa M. MitchellShehzad BasariaWilliam E. BodenGlenn R. CunninghamChristopher B. GrangerMohit KheraIan M. ThompsonJr.Jr., Qiuqing WangKathy WolskiDeborah DaveyVidyasagar KalahastiNader KhanMichael G. MillerMichael C. SnabesAnna ChanElena DubcencoXue LiTingting YiBidan HuangKarol M. PencinaThomas G. TravisonSteven E. Nissen. (2023) Cardiovascular Safety of Testosterone-Replacement Therapy. New England Journal of Medicine 389:2, pages 107-117.
Crossref
Crossref
Ta-Wei Lee, Pei-Yu Kao, Yang-Ching Chen & Sen-Te Wang. (2023) Effects of Testosterone Replacement Therapy on Muscle Strength in Older Men with Low to Low-Normal Testosterone Levels: A Systematic Review and Meta‐Analysis. Gerontology 69:10, pages 1157-1166.
Crossref
Crossref
Hossein Chiti, Negin Parsamanesh, Željko Reiner, Tannaz Jamialahmadi & Amirhossein Sahebkar. 2023. Principles of Gender-Specific Medicine. Principles of Gender-Specific Medicine
551
571
.
Ricardo Martins da Rocha Meirelles. 2023. Testosterone. Testosterone
177
191
.
Rakesh Iyer & David J. Handelsman. 2023. Testosterone. Testosterone
481
508
.
Bu B. Yeap. 2023. Testosterone. Testosterone
381
410
.
Jeremy M. Auerbach & Mohit Khera. (2022) Testosterone replacement therapy and cardiovascular disease. International Journal of Impotence Research 34:7, pages 685-690.
Crossref
Crossref
Joshua White, Francis Petrella & Jesse Ory. (2022) Testosterone therapy and secondary erythrocytosis. International Journal of Impotence Research 34:7, pages 693-697.
Crossref
Crossref
Jens Rosellen, Thorsten Diemer, Arne Hauptmann & Florian Wagenlehner. (2022) TestosterontherapieTestosterone treatment. Die Urologie 61:11, pages 1260-1275.
Crossref
Crossref
Farouk M. El-Khatib, Linda M. Huynh, Alexei Kopelevich, Mohamad M. Osman, Edward Choi, Jeanie T. Nguyen, Sharmin Dianatnejad, Qiaqia Wu, Madeline G. Olivas, Aaron Spitz, Jacob Lowry, Boriss Y. Losso, Mohit Khera, Laura Angulo-Llanos, Premal Patel, Ranjith Ramasamy & Faysal A. Yafi. (2021) Comparative assessment of outcomes and adverse effects using two different intramuscular testosterone therapy regimens: 100 mg IM weekly or 200 mg IM biweekly. International Journal of Impotence Research 34:6, pages 558-563.
Crossref
Crossref
Phillip Kim & Raul I. Clavijo. (2022) Management of male sexual dysfunction after cancer treatment. Urologic Oncology: Seminars and Original Investigations 40:9, pages 389-394.
Crossref
Crossref
Mercedes Perusquía. (2022) Androgens and Non-Genomic vascular responses in hypertension. Biochemical Pharmacology 203, pages 115200.
Crossref
Crossref
Giuseppe Fallara, Edoardo Pozzi, Federico Belladelli, Christian Corsini, Luca Boeri, Paolo Capogrosso, Francesco Montorsi & Andrea Salonia. (2022) Cardiovascular Morbidity and Mortality in Men – Findings from a Meta-analysis on the Time-related Measure of Risk of Exogenous Testosterone. The Journal of Sexual Medicine 19:8, pages 1243-1254.
Crossref
Crossref
Ananias C. Diokno. (2022) The role of testosterone in men’s health: is it time for a new approach?. International Urology and Nephrology 54:11, pages 2767-2774.
Crossref
Crossref
Giuseppe Fallara, Edoardo Pozzi, Christian Corsini, Federico Belladelli, Luca Boeri, Paolo Capogrosso, Francesco Montorsi & Andrea Salonia. (2022) Morbidity and mortality in men: Role of androgens. Best Practice & Research Clinical Endocrinology & Metabolism 36:4, pages 101662.
Crossref
Crossref
Jemma Hudson, Moira Cruickshank, Richard Quinton, Lorna Aucott, Magaly Aceves-Martins, Katie Gillies, Shalender Bhasin, Peter J Snyder, Susan S Ellenberg, Mathis Grossmann, Thomas G Travison, Emily J Gianatti, Yvonne T van der Schouw, Marielle H Emmelot-Vonk, Erik J Giltay, Geoff Hackett, Sudarshan Ramachandran, Johan Svartberg, Kerry L Hildreth, Kristina Groti Antonic, Gerald B Brock, J Lisa Tenover, Hui Meng Tan, Christopher Ho Chee Kong, Wei Shen Tan, Leonard S Marks, Richard J Ross, Robert S Schwartz, Paul Manson, Stephen Roberts, Marianne Skovsager Andersen, Line Velling Magnussen, Rodolfo Hernández, Nick Oliver, Frederick Wu, Waljit S Dhillo, Siladitya Bhattacharya, Miriam Brazzelli & Channa N Jayasena. (2022) Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis. The Lancet Healthy Longevity 3:6, pages e381-e393.
Crossref
Crossref
Luigi Di Filippo, Rebecca De Lorenzo, Andrea Giustina, Patrizia Rovere-Querini & Caterina Conte. (2022) Vitamin D in Osteosarcopenic Obesity. Nutrients 14:9, pages 1816.
Crossref
Crossref
Sandeep Dhindsa. 2022. Pathy's Principles and Practice of Geriatric Medicine. Pathy's Principles and Practice of Geriatric Medicine
1073
1085
.
Paolo Emilio Adami, Nikolaos Koutlianos, Aaron Baggish, Stéphane Bermon, Elena Cavarretta, Asterios Deligiannis, Francesco Furlanello, Evangelia Kouidi, Pedro Marques-Vidal, Josef Niebauer, Antonio Pelliccia, Sanjay Sharma, Erik Ekker Solberg, Mark Stuart & Michael Papadakis. (2022) Cardiovascular effects of doping substances, commonly prescribed medications and ergogenic aids in relation to sports: a position statement of the sport cardiology and exercise nucleus of the European Association of Preventive Cardiology. European Journal of Preventive Cardiology 29:3, pages 559-575.
Crossref
Crossref
Biagio Barone, Luigi Napolitano, Marco Abate, Luigi Cirillo, Pasquale Reccia, Francesco Passaro, Carmine Turco, Simone Morra, Francesco Mastrangelo, Antonio Scarpato, Ugo Amicuzi, Vincenzo Morgera, Lorenzo Romano, Francesco Paolo Calace, Savio Domenico Pandolfo, Luigi De Luca, Achille Aveta, Enrico Sicignano, Massimiliano Trivellato, Gianluca Spena, Carlo D’Alterio, Giovanni Maria Fusco, Raffaele Vitale, Davide Arcaniolo & Felice Crocetto. (2022) The Role of Testosterone in the Elderly: What Do We Know?. International Journal of Molecular Sciences 23:7, pages 3535.
Crossref
Crossref
Abraham Morgentaler, Kunal LodayaSantosh TelangDavid K. HayashidaYiqun Hu. (2022) Comparison of Patterns of Use and Clinical Outcomes Between Injections of Testosterone Undecanoate and Testosterone Cypionate: An Electronic Health Record Cohort Study. Androgens: Clinical Research and Therapeutics 3:1, pages 31-40.
Crossref
Crossref
Christina Wang & Ronald S. Swerdloff. (2022) Testosterone Replacement Therapy in Hypogonadal Men. Endocrinology and Metabolism Clinics of North America 51:1, pages 77-98.
Crossref
Crossref
Shalender Bhasin, A. Michael Lincoff, Shehzad Basaria, Douglas C. Bauer, William E. Boden, Glenn R. Cunningham, Deborah Davey, Elena Dubcenco, Sandra Fukumoto, Michelle Garcia, Christopher B. Granger, Vidyasagar Kalahasti, Mohit Khera, Michael G. Miller, Lisa M. Mitchell, Michael P. O'Leary, Karol M. Pencina, Peter J. Snyder, Ian M. ThompsonJr.Jr., Thomas G. Travison, Kathy Wolski & Steven E. Nissen. (2022) Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study. American Heart Journal 245, pages 41-50.
Crossref
Crossref
Bailey N Goyette, Matthew T Hudnall & Joshua A Halpern. (2022) Testosterone Use in the Perioperative Setting. Current Sexual Health Reports 14:1, pages 1-8.
Crossref
Crossref
I. I. Dedov, N. G. Mokrysheva, G. A. Melnichenko, R. V. Rozhivanov, A. A. Kamalov, А. M. Mkrtumyan, Yu. Sh. Khalimov & N. V. Vorokhobina. (2022) Draft of Russian Clinical Practice Guidelines «Male hypogonadism». Obesity and metabolism 18:4, pages 496-507.
Crossref
Crossref
Channa N. Jayasena, Richard A. Anderson, Sofia Llahana, Julian H. Barth, Finlay MacKenzie, Scott Wilkes, Neil Smith, Prasanna Sooriakumaran, Sukhbinder Minhas, Frederick C. W. Wu, Jeremy Tomlinson & Richard Quinton. (2021) Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism. Clinical Endocrinology 96:2, pages 200-219.
Crossref
Crossref
David J. Handelsman. (2022) The Illusory Case for Treatment of an Invented Disease. Frontiers in Endocrinology 12.
Crossref
Crossref
Alexandre Hohl & Marcelo Fernando Ronsoni. 2022. Endocrinology and Diabetes. Endocrinology and Diabetes
139
155
.
Prachi Singh, Naima Covassin, Kara Marlatt, Kishore M. Gadde & Steven B. Heymsfield. 2011. Comprehensive Physiology. Comprehensive Physiology
2949
2993
.
Lijun Yin, Man Luo, Ru Wang, Jianping Ye & Xiaohui Wang. (2021) Mitochondria in Sex Hormone-Induced Disorder of Energy Metabolism in Males and Females. Frontiers in Endocrinology 12.
Crossref
Crossref
Е.V. Luchytskiy & V.E. Luchytskiy. (2021) Erectile dysfunction in men with diabetes (literature review). Part 2. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) 17:6, pages 513-519.
Crossref
Crossref
Andrea Salonia, Carlo Bettocchi, Luca Boeri, Paolo Capogrosso, Joana Carvalho, Nusret Can Cilesiz, Andrea Cocci, Giovanni Corona, Kostantinos Dimitropoulos, Murat Gül, Georgios Hatzichristodoulou, T. Hugh Jones, Ates Kadioglu, Juan Ignatio Martínez Salamanca, Uros Milenkovic, Vaibhav Modgil, Giorgio Ivan Russo, Ege Can Serefoglu, Tharu Tharakan, Paolo Verze & Suks Minhas. (2021) European Association of Urology Guidelines on Sexual and Reproductive Health—2021 Update: Male Sexual Dysfunction. European Urology 80:3, pages 333-357.
Crossref
Crossref
David J Handelsman. (2021) Androgen Misuse and Abuse. Endocrine Reviews 42:4, pages 457-501.
Crossref
Crossref
Xiao ZhangKe HuangFarid SaadKarim Sultan HaiderAhmad HaiderXiaohui Xu. (2021) Testosterone Therapy Reduces Cardiovascular Risk Among Hypogonadal Men: A Prospective Cohort Study in Germany. Androgens: Clinical Research and Therapeutics 2:1, pages 64-72.
Crossref
Crossref
Jelani K. Grant, Quentin Loyd & Claudia Martinez. (2021) Testosterone, HIV, and cardiovascular disease risk. Cardiovascular Endocrinology & Metabolism 10:2, pages 72-79.
Crossref
Crossref
Maxwell Towe, Farouk El-Khatib, Mohamad Osman, Linda Huynh, Rafael Carrion, Sam Ward, Yavoc Reisman, Ege Can Serefoglu, Alexander Pastuszak & Faysal A. Yafi. (2020) “Doc, if it were you, what would you do?”: a survey of Men’s Health specialists’ personal preferences regarding treatment modalities. International Journal of Impotence Research 33:3, pages 303-310.
Crossref
Crossref
Luca Maria Schönauer, Miriam Dellino, Matteo Loverro, Carmine Carriero, Teresa Capursi, Claudia Leoni, Giuseppe Loverro & Edoardo Di Naro. (2020) Hormone therapy in female-to-male transgender patients: searching for a lifelong balance. Hormones 20:1, pages 151-159.
Crossref
Crossref
Sarah Costa, Ardan M. Saguner, Alessio Gasperetti, Deniz Akdis, Corinna Brunckhorst & Firat Duru. (2021) The Link Between Sex Hormones and Susceptibility to Cardiac Arrhythmias: From Molecular Basis to Clinical Implications. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
I. I. Dedov, M. V. Shestakova, G. A. Melnichenko, N. V. Mazurina, E. N. Andreeva, I. Z. Bondarenko, Z. R. Gusova, F. K. Dzgoeva, M. S. Eliseev, E. V. Ershova, M. V. Zhuravleva, T. A. Zakharchuk, V. A. Isakov, M. V. Klepikova, K. A. Komshilova, V. S. Krysanova, S. V. Nedogoda, A. M. Novikova, O. D. Ostroumova, A. P. Pereverzev, R. V. Rozhivanov, T. I. Romantsova, L. A. Ruyatkina, A. S. Salasyuk, A. N. Sasunova, S. A. Smetanina, A. V. Starodubova, L. A. Suplotova, O. N. Tkacheva, E. A. Troshina, M. V. Khamoshina, S. M. Chechelnitskaya, E. A. Shestakova & E. V. Sheremet’eva. (2021) INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES". Obesity and metabolism 18:1, pages 5-99.
Crossref
Crossref
Adrian Eugen Roşca, Ana-Maria Vlădăreanu, Alina Mititelu, Bogdan Ovidiu Popescu, Corin Badiu, Constantin Căruntu, Suzana Elena Voiculescu, Minodora Onisâi, Şerban Gologan, Radu Mirica & Leon Zăgrean. (2021) Effects of Exogenous Androgens on Platelet Activity and Their Thrombogenic Potential in Supraphysiological Administration: A Literature Review. Journal of Clinical Medicine 10:1, pages 147.
Crossref
Crossref
Paresh Dandona, Sandeep Dhindsa, Husam Ghanim & Farid Saad. (2020) Mechanisms underlying the metabolic actions of testosterone in humans: A narrative review. Diabetes, Obesity and Metabolism 23:1, pages 18-28.
Crossref
Crossref
Mohit Khera, Martin Miner, Jonathan Jaffe & Alexander W. Pastuszak. (2021) Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased Risk. The Journal of Sexual Medicine 18:1, pages 83-98.
Crossref
Crossref
Sayantan Ray & Subhodip Pramanik. (2020) Reproductive Dysfunctions in Males with Type 2 Diabetes Mellitus: An Updated Review. EMJ Diabetes, pages 79-89.
Crossref
Crossref
Ronald Swerdloff & Christina Wang. (2020) Reflections on the T Trials. Andrology 8:6, pages 1512-1518.
Crossref
Crossref
Franz Sesti, Riccardo Pofi, Marianna Minnetti, Marta Tenuta, Daniele Gianfrilli & Andrea M. Isidori. (2020)
Late‐onset hypogonadism:
Reductio ad absurdum
of the cardiovascular risk‐benefit of testosterone replacement therapy
. Andrology 8:6, pages 1614-1627.
Crossref
Crossref
E. Nieschlag. (2019) Late‐onset hypogonadism: a concept comes of age. Andrology 8:6, pages 1506-1511.
Crossref
Crossref
Jamal C Perry, Tayná M Schuetz, Mohammad D Memon, Sadaf Faiz & Ivan Cancarevic. (2020) Anabolic Steroids and Cardiovascular Outcomes: The Controversy. Cureus.
Crossref
Crossref
Tharu Tharakan, Carlo Bettocchi, Joana Carvalho, Giovanni Corona, Ulla N. Joensen, Hugh Jones, Ates Kadioglu, Juan I. Martínez Salamanca, Ege C. Serefoglu, Paolo Verze, Julie Darraugh, Karin Plass, James N’Dow, Andrea Salonia & Suks Minhas. (2020) Male Sexual and Reproductive Health—Does the Urologist Have a Role in Addressing Gender Inequality in Life Expectancy?. European Urology Focus 6:4, pages 791-800.
Crossref
Crossref
Michael Zitzmann. (2020) Testosterontherapie im Alter bei Hypogonadismus und KomorbiditätenTestosterone replacement treatment in older people with and without co-morbidities. Der Internist 61:6, pages 549-557.
Crossref
Crossref
Maged Y. Argalious, John Steib, Nikolas Daskalakis, Guangmei Mao, Minwei Li, Sherif Armanyous & Eric Roselli. (2020) Association of Testosterone Replacement Therapy and the Incidence of a Composite of Postoperative In-Hospital Mortality and Cardiovascular Events in Men Undergoing Cardiac Surgery. Anesthesia & Analgesia 130:4, pages 890-898.
Crossref
Crossref
Giovanni Corona, Luiz Otavio Torres & Mario Maggi. (2020) Testosterone Therapy: What We Have Learned From Trials. The Journal of Sexual Medicine 17:3, pages 447-460.
Crossref
Crossref
Marco Marcelli & Sanjay Navin Mediwala. (2023) Male Hypogonadism: A Review. Journal of Investigative Medicine 68:2, pages 335-356.
Crossref
Crossref
Geoffrey Hackett, Nigel ColeAkhilesh MulayRichard C. StrangeSudarshan Ramachandran. (2020) Long-Term Testosterone Therapy in Type 2 Diabetes Is Associated with Decreasing Waist Circumference and Improving Erectile Function. The World Journal of Men's Health 38:1, pages 68.
Crossref
Crossref
V. Mirone & R. La Rocca. 2020. Urologic Principles and Practice. Urologic Principles and Practice
151
158
.
A. Sansone, M. Sansone, R. Selleri, A. Schiavo, D. Gianfrilli, C. Pozza, M. Zitzmann, A. Lenzi & F. Romanelli. (2019) Monitoring testosterone replacement therapy with transdermal gel: when and how?. Journal of Endocrinological Investigation 42:12, pages 1491-1496.
Crossref
Crossref
G. Piccirillo, F. Moscucci, R. Pofi, G. D’Alessandro, M. Minnetti, A. M. Isidori, D. Francomano, A. Lenzi, P. E. Puddu, J. Alexandre, D. Magrì & A. Aversa. (2019) Changes in left ventricular repolarization after short-term testosterone replacement therapy in hypogonadal males. Journal of Endocrinological Investigation 42:9, pages 1051-1065.
Crossref
Crossref
Geoffrey Hackett. (2019) Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome. Sexual Medicine Reviews 7:3, pages 476-490.
Crossref
Crossref
Mikkel Fode, Andrea Salonia, Suks Minhas, Arthur L. Burnett & Alan W. Shindel. (2019) Late-onset Hypogonadism and Testosterone Therapy – A Summary of Guidelines from the American Urological Association and the European Association of Urology. European Urology Focus 5:4, pages 539-544.
Crossref
Crossref
Du Soon Swee & Earn H. Gan. (2019) Late-Onset Hypogonadism as Primary Testicular Failure. Frontiers in Endocrinology 10.
Crossref
Crossref
Andrea Salonia, Giulia Rastrelli, Geoffrey Hackett, Stephanie B. Seminara, Ilpo T. Huhtaniemi, Rodolfo A. Rey, Wayne J. G. Hellstrom, Mark R. Palmert, Giovanni Corona, Gert R. Dohle, Mohit Khera, Yee-Ming Chan & Mario Maggi. (2019) Paediatric and adult-onset male hypogonadism. Nature Reviews Disease Primers 5:1.
Crossref
Crossref
Carol Cardona Attard & Stephen Fava. (2019) Benefits and risks of testosterone therapy in older men. Minerva Urologica e Nefrologica 71:3.
Crossref
Crossref
Ronni Hayon & Kristin Stevenson. (2019) Hormonal, Medical, and Nonsurgical Aspects of Gender Affirmation. Facial Plastic Surgery Clinics of North America 27:2, pages 179-190.
Crossref
Crossref
Hyun Park, Sun Ahn & Du Moon. (2019) Evolution of Guidelines for Testosterone Replacement Therapy. Journal of Clinical Medicine 8:3, pages 410.
Crossref
Crossref
Channa N. Jayasena, Fatima M. Alkaabi, Curtis S. Liebers, Thomas Handley, Stephen Franks & Waljit S. Dhillo. (2019) A systematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal women. Clinical Endocrinology 90:3, pages 391-414.
Crossref
Crossref
Geoffrey Hackett, Nigel Cole, Akhilesh Mulay, Richard C. Strange & Sudarshan Ramachandran. (2018) Long‐term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors. BJU International 123:3, pages 519-529.
Crossref
Crossref
Geoffrey Hackett. (2019) Type 2 Diabetes and Testosterone Therapy. The World Journal of Men's Health 37:1, pages 31.
Crossref
Crossref
Cornelius J Fernandez, Elias C Chacko & Joseph M Pappachan. (2019) Male Obesity-related Secondary Hypogonadism – Pathophysiology, Clinical Implications and Management. European Endocrinology 15:2, pages 83.
Crossref
Crossref
James Anaissie, Alexander W. Pastuszak & Mohit Khera. 2019. Effects of Lifestyle on Men's Health. Effects of Lifestyle on Men's Health
235
251
.
G. Rastrelli, Y. Reisman, S. Ferri, O. Prontera, A. Sforza, M. Maggi & G. Corona. 2019. Sexual Medicine. Sexual Medicine
79
93
.
MOLLY B. MORAVEK. (2018) Gender-Affirming Hormone Therapy for Transgender Men. Clinical Obstetrics & Gynecology 61:4, pages 687-704.
Crossref
Crossref
Francesco Sessa, Monica Salerno, Giulio Di Mizio, Giuseppe Bertozzi, Giovanni Messina, Benedetta Tomaiuolo, Daniela Pisanelli, Francesca Maglietta, Pietrantonio Ricci & Cristoforo Pomara. (2018) Anabolic Androgenic Steroids: Searching New Molecular Biomarkers. Frontiers in Pharmacology 9.
Crossref
Crossref
Aulona Gaba, Mario Mairhofer, Zyhdi Zhegu, Nadja Leditznig, Ladislaus Szabo, Walter Tschugguel, Christian Schneeberger & Iveta Yotova. (2018) Testosterone induced downregulation of migration and proliferation in human Umbilical Vein Endothelial Cells by Androgen Receptor dependent and independent mechanisms. Molecular and Cellular Endocrinology 476, pages 173-184.
Crossref
Crossref
Gustavo Monnerat, Fernando A.C. Seara, Joseph Albert Medeiros Evaristo, Gabriel Carneiro, Geisa Paulino Caprini Evaristo, Gilberto Domont, Jose Hamilton Matheus Nascimento, Jose Geraldo Mill, Fabio Cesar Souza Nogueira & Antonio Carlos Campos de Carvalho. (2018) Aging-related compensated hypogonadism: Role of metabolomic analysis in physiopathological and therapeutic evaluation. The Journal of Steroid Biochemistry and Molecular Biology 183, pages 39-50.
Crossref
Crossref
Andreas Lundh, Joel Lexchin, Barbara Mintzes, Jeppe B. Schroll & Lisa Bero. (2018) Industry sponsorship and research outcome: systematic review with meta-analysis. Intensive Care Medicine 44:10, pages 1603-1612.
Crossref
Crossref
Christina Dimopoulou, Dimitrios G. Goulis, Giovanni Corona & Mario Maggi. (2018) The complex association between metabolic syndrome and male hypogonadism. Metabolism 86, pages 61-68.
Crossref
Crossref
Christos P. Tsametis & Andrea M. Isidori. (2018) Testosterone replacement therapy: For whom, when and how?. Metabolism 86, pages 69-78.
Crossref
Crossref
Giovanni Corona, Giulia Rastrelli, Giuseppe Di Pasquale, Alessandra Sforza, Edoardo Mannucci & Mario Maggi. (2018) Endogenous Testosterone Levels and Cardiovascular Risk: Meta-Analysis of Observational Studies. The Journal of Sexual Medicine 15:9, pages 1260-1271.
Crossref
Crossref
John P. Mulhall, Landon W. Trost, Robert E. Brannigan, Emily G. Kurtz, J. Bruce Redmon, Kelly A. Chiles, Deborah J. Lightner, Martin M. Miner, M. Hassan Murad, Christian J. Nelson, Elizabeth A. Platz, Lakshmi V. Ramanathan & Ronald W. Lewis. (2018) Evaluation and Management of Testosterone Deficiency: AUA Guideline. The Journal of Urology 200:2, pages 423-432.
Crossref
Crossref
Sandeep Dhindsa, Husam Ghanim, Manav Batra & Paresh Dandona. (2018) Hypogonadotropic Hypogonadism in Men With Diabesity. Diabetes Care 41:7, pages 1516-1525.
Crossref
Crossref
Martin Miner, Abraham Morgentaler, Mohit Khera & Abdulmaged M. Traish. (2018) The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk. Clinical Endocrinology 89:1, pages 3-10.
Crossref
Crossref
Giovanni Corona, Giulia Rastrelli, Giuseppe Di Pasquale, Alessandra Sforza, Edoardo Mannucci & Mario Maggi. (2018) Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies. The Journal of Sexual Medicine 15:6, pages 820-838.
Crossref
Crossref
Phelan E. Maruca-Sullivan, Sarah A. Kleinfeld & Kirsten M. Wilkins. (2018) Treatment Approaches to Sexual Dysfunction in Late Life. Current Treatment Options in Psychiatry 5:2, pages 255-274.
Crossref
Crossref
Mark D. Peterson, Aleksandr Belakovskiy, Ryan McGrath & Joshua F. Yarrow. (2018) Testosterone Deficiency, Weakness, and Multimorbidity in Men. Scientific Reports 8:1.
Crossref
Crossref
Martin M. Miner, Joel Heidelbaugh, Mark Paulos, Allen D. Seftel, Jason Jameson & Steven A. Kaplan. (2018) The Intersection of Medicine and Urology. Medical Clinics of North America 102:2, pages 399-415.
Crossref
Crossref
Jonathan Clavell-Hernández & Run Wang. (2018) Emerging Evidences in the Long Standing Controversy Regarding Testosterone Replacement Therapy and Cardiovascular Events. The World Journal of Men's Health 36:2, pages 92.
Crossref
Crossref
Abdulmaged M. Traish. (2018) Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency. Sexual Medicine Reviews 6:1, pages 86-105.
Crossref
Crossref
Samuel J. Ohlander, Bibin Varghese & Alexander W. Pastuszak. (2018) Erythrocytosis Following Testosterone Therapy. Sexual Medicine Reviews 6:1, pages 77-85.
Crossref
Crossref
Cindy Pham, Christina Wang & Ronald Swerdloff. 2018. Encyclopedia of Endocrine Diseases. Encyclopedia of Endocrine Diseases
735
740
.
Brian T. Nguyen, Ronald Swerdloff, Frederick C.W. Wu & Christina Wang. 2018. Encyclopedia of Endocrine Diseases. Encyclopedia of Endocrine Diseases
741
750
.
Tuğba Erdoğan, Gülistan Bahat & Mehmet Akif Karan. 2018. Molecular Basis and Emerging Strategies for Anti-aging Interventions. Molecular Basis and Emerging Strategies for Anti-aging Interventions
305
322
.
Zaneb Yaseen. 2018. Masterful Care of the Aging Athlete. Masterful Care of the Aging Athlete
45
58
.
Ivan I. Dedov, Galina A. Mel'nichenko, Marina V. Shestakova, Roman V. Rozhivanov, Anna L. Terehova, Alexey V. Zilov, Daria O. Ladygina & Dmitriy G. Kurbatov. (2017) Guidelines for the Diagnosis and Treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus. Obesity and metabolism 14:4, pages 83-92.
Crossref
Crossref
Giovanni Corona, Giulia Rastrelli, Mauro Dicuio, Alessandra Sforza & Mario Maggi. (2017) Testosterone and Cardiovascular Diseases: Causes or Consequences: The Lesson from the Last 5 Years. Current Sexual Health Reports 9:4, pages 277-289.
Crossref
Crossref
Jason Akerman, Jason R. Kovac & Larry I. Lipshultz. (2017) Testosterone therapy improves well being and psychological health. Current Opinion in Urology 27:6, pages 519-524.
Crossref
Crossref
Erik L. Knight, Colton B. Christian, Pablo J. Morales, William T. Harbaugh, Ulrich Mayr & Pranjal H. Mehta. (2017) Exogenous testosterone enhances cortisol and affective responses to social-evaluative stress in dominant men. Psychoneuroendocrinology 85, pages 151-157.
Crossref
Crossref
Hu Li, Lucy Mitchell, Xiang Zhang, Darell Heiselman & Stephen Motsko. (2017) Testosterone Therapy and Risk of Acute Myocardial Infarction in Hypogonadal Men: An Administrative Health Care Claims Study. The Journal of Sexual Medicine 14:11, pages 1307-1317.
Crossref
Crossref
Mark Ng Tang Fui, Rudolf Hoermann, Jeffrey D. Zajac & Mathis Grossmann. (2017) The effects of testosterone on body composition in obese men are not sustained after cessation of testosterone treatment. Clinical Endocrinology 87:4, pages 336-343.
Crossref
Crossref
Richard V. Clark, Ann C. Walker, Susan Andrews, Philip Turnbull, Jeffrey A. Wald & Mindy H. Magee. (2017) Safety, pharmacokinetics and pharmacological effects of the selective androgen receptor modulator, GSK2881078, in healthy men and postmenopausal women. British Journal of Clinical Pharmacology 83:10, pages 2179-2194.
Crossref
Crossref
Abdulmaged M. Traish, Ahmad Haider, Karim Sultan Haider, Gheorghe Doros & Farid Saad. (2017) Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism. Journal of Cardiovascular Pharmacology and Therapeutics 22:5, pages 414-433.
Crossref
Crossref
Maged Y. ArgaliousJing YouGuangmei MaoDaniel RamosSandeep KhannaKamal MaheshwariCarlos Trombetta. (2017) Association of Testosterone Replacement Therapy and the Incidence of a Composite of Postoperative In-hospital Mortality and Cardiovascular Events in Men Undergoing Noncardiac Surgery. Anesthesiology 127:3, pages 457-465.
Crossref
Crossref
Alexander W. Pastuszak, Taylor P. Kohn, Joel Estis & Larry I. Lipshultz. (2017) Low Plasma Testosterone Is Associated With Elevated Cardiovascular Disease Biomarkers. The Journal of Sexual Medicine 14:9, pages 1095-1103.
Crossref
Crossref
G Corona, M Dicuio, G Rastrelli, E Maseroli, F Lotti, A Sforza & M Maggi. (2023) Testosterone Treatment and Cardiovascular and Venous Thromboembolism Risk: What is ‘New’?. Journal of Investigative Medicine 65:6, pages 964-973.
Crossref
Crossref
Faysal A. Yafi, Nora M. Haney, James Anaissie, Kenneth J. DeLay, Landon Trost, Mohit Khera & Wayne J.G. Hellstrom. (2017) Practice Patterns in the Diagnosis and Management of Hypogonadism: A Survey of Sexual Medicine Society of North America Members. Urology 106, pages 87-95.
Crossref
Crossref
Vincenzo Mirone, Frans Debruyne, Gert Dohle, Andrea Salonia, Nikolaos Sofikitis, Paolo Verze, Mikkel Fode & Christopher Chapple. (2017) European Association of Urology Position Statement on the Role of the Urologist in the Management of Male Hypogonadism and Testosterone Therapy. European Urology 72:2, pages 164-167.
Crossref
Crossref
Syukri Rahim. (2017) Testosterone deficiency. InnovAiT: Education and inspiration for general practice 10:7, pages 393-401.
Crossref
Crossref
Angela K. Lucas-HeraldRheure Alves-LopesAugusto C. MontezanoS. Faisal AhmedRhian M. Touyz. (2017) Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications. Clinical Science 131:13, pages 1405-1418.
Crossref
Crossref
Olurinde A. Oni, Rishi Sharma, Guoqing Chen, Mukut Sharma, Kamal Gupta, Buddhadeb Dawn, Ram Sharma, Deepak Parashara, Virginia J. Savin, George Cherian, John A. Ambrose & Rajat S. Barua. (2017) Normalization of Testosterone Levels After Testosterone Replacement Therapy Is Not Associated With Reduced Myocardial Infarction in Smokers. Mayo Clinic Proceedings: Innovations, Quality & Outcomes 1:1, pages 57-66.
Crossref
Crossref
Galina Afanas'evna Melnichenko, Marina Vladimirovna Shestakova, Roman Viktorovich Rozhivanov, Anna Leont'evna Terehova, Alexey Vadimovich Zilov, Daria Olegovna Ladygina & Dmitriy Gennad'evich Kurbatov. (2017) Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft). Diabetes mellitus 20:2, pages 151-160.
Crossref
Crossref
Y. Nian, M. Ding, S. Hu, H. He, S. Cheng, L. Yi, Y. Li & Y. Wang. (2017) Testosterone replacement therapy improves health-related quality of life for patients with late-onset hypogonadism: a meta-analysis of randomized controlled trials. Andrologia 49:4, pages e12630.
Crossref
Crossref
Leon I. Igel, Rekha B. Kumar, Katherine H. Saunders & Louis J. Aronne. (2017) Practical Use of Pharmacotherapy for Obesity. Gastroenterology 152:7, pages 1765-1779.
Crossref
Crossref
Travis Goodale, Archana Sadhu, Steven Petak & Richard Robbins. (2017) Testosterone and the Heart. Methodist DeBakey Cardiovascular Journal 13:2, pages 68-72.
Crossref
Crossref
Nicholas Fuggle, Sarah Shaw, Elaine Dennison & Cyrus Cooper. (2017) Sarcopenia. Best Practice & Research Clinical Rheumatology 31:2, pages 218-242.
Crossref
Crossref
Geoffrey I. Hackett. 2017. Diabetes in Old Age. Diabetes in Old Age
148
166
.
Benjamin Chin-Yee, Alejandro Lazo-Langner, Terrie Butler-Foster, Cyrus Hsia & Ian Chin-Yee. (2017) Blood donation and testosterone replacement therapy. Transfusion 57:3, pages 578-581.
Crossref
Crossref
Geoffrey Hackett, Michael Kirby, David Edwards, T. Hugh Jones, Jonathan Rees & Asif Muneer. (2017) UK policy statements on testosterone deficiency. International Journal of Clinical Practice 71:3-4, pages e12901.
Crossref
Crossref
Mercedes Perusquía, Nieves Herrera, Mercedes Ferrer & John N. Stallone. (2017) Antihypertensive effects of androgens in conscious, spontaneously hypertensive rats. The Journal of Steroid Biochemistry and Molecular Biology 167, pages 106-114.
Crossref
Crossref
G. Caleb Alexander, Geetha Iyer, Eleanor Lucas, Dora Lin & Sonal Singh. (2017) Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis. The American Journal of Medicine 130:3, pages 293-305.
Crossref
Crossref
Katarzyna Piotrowska, Christina Wang, Ronald S Swerdloff & Peter Y Liu. (2017) Male hormonal contraception: hope and promise. The Lancet Diabetes & Endocrinology 5:3, pages 214-223.
Crossref
Crossref
Andreas Lundh, Joel Lexchin, Barbara Mintzes, Jeppe B Schroll & Lisa Bero. (2017) Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews 2017:2.
Crossref
Crossref
Andrea SansoneMassimiliano SansoneAndrea LenziFrancesco Romanelli. (2017) Testosterone Replacement Therapy: The Emperor's New Clothes. Rejuvenation Research 20:1, pages 9-14.
Crossref
Crossref
Giovanni CoronaAlessandra SforzaMario Maggi. (2017) Testosterone Replacement Therapy: Long-Term Safety and Efficacy. The World Journal of Men's Health 35:2, pages 65.
Crossref
Crossref
William A. Fisher, Ilan Gruenwald, Emmanuele A. Jannini, Ahinoam Lev-Sagie, Lior Lowenstein, Robert E. Pyke, Yakov Reisman, Dennis A. Revicki & Eusebio Rubio-Aurioles. (2017) Standards for Clinical Trials in Male and Female Sexual Dysfunction: III. Unique Aspects of Clinical Trials in Male Sexual Dysfunction. The Journal of Sexual Medicine 14:1, pages 3-18.
Crossref
Crossref
Nikhil Gupta, Maria Carvajal, Michael Jurewicz & Bruce R. Gilbert. (2017) Bulbocavernosus muscle area as a novel marker for hypogonadism. Asian Journal of Urology 4:1, pages 3-9.
Crossref
Crossref
Wenyi Zhang, Moizza Shabbir & Peter Y. Liu. 2017. Male Hypogonadism. Male Hypogonadism
399
422
.
Jonas Čeponis, Ronald S. Swerdloff & Christina Wang. 2017. Male Hypogonadism. Male Hypogonadism
367
397
.
Ricardo Martins da Rocha Meirelles. 2017. Testosterone. Testosterone
147
159
.
Rakesh Iyer & David J. Handelsman. 2017. Testosterone. Testosterone
375
402
.
Bu B. Yeap. 2017. Testosterone. Testosterone
299
318
.
David J. Handelsman. 2017. Endocrinology of the Testis and Male Reproduction. Endocrinology of the Testis and Male Reproduction
1251
1285
.
Giulia Rastrelli & Mario Maggi. 2017. Endocrinology of the Testis and Male Reproduction. Endocrinology of the Testis and Male Reproduction
945
978
.
Vincenzo Rochira. 2017. Endocrinology of the Testis and Male Reproduction. Endocrinology of the Testis and Male Reproduction
829
879
.
Carlo Maria Rotella, Ilaria Dicembrini & Laura Pala. 2017. Integrative Cardiology. Integrative Cardiology
99
107
.
David J. Handelsman. 2017. Thyroid Diseases. Thyroid Diseases
1
35
.
Giulia Rastrelli & Mario Maggi. 2017. Thyroid Diseases. Thyroid Diseases
1
34
.
Vincenzo Rochira. 2017. Thyroid Diseases. Thyroid Diseases
1
51
.
Evelyn M. Wong, Anna Lehman, Philip Acott, Jane Gillis, Daniel L. Metzger & Sandra Sirrs. 2017. JIMD Reports, Volume 36. JIMD Reports, Volume 36
79
84
.
Mohit Khera, Ganesh Adaikan, Jacques Buvat, Serge Carrier, Amr El-Meliegy, Kostas Hatzimouratidis, Andrew McCullough, Abraham Morgentaler, Luiz Otavio Torres & Andrea Salonia. (2016) Diagnosis and Treatment of Testosterone Deficiency: Recommendations from the Fourth International Consultation for Sexual Medicine (ICSM 2015). The Journal of Sexual Medicine 13:12, pages 1787-1804.
Crossref
Crossref
Dimitri C. Cassimatis, Matthew T. Crim & Nanette K. Wenger. (2016) Low Testosterone in Men with Cardiovascular Disease or Risk Factors: To Treat or Not To Treat?. Current Treatment Options in Cardiovascular Medicine 18:12.
Crossref
Crossref
Abraham Morgentaler, M. Zitzmann, A. M. Traish, A. W. Fox, T. H. Jones, M. Maggi, S. Arver, A. Aversa, J.C.N. Chan, A. S. Dobs, G. I. Hackett, W. J. Hellstrom, P. Lim, B. Lunenfeld, G. Mskhalaya, C. C. Schulman & L. O. Torres. (2016) The consensus recommendations of a group of international experts on the fundamental concepts related to the issues of testosterone deficiency and its treatment.. Obesity and metabolism 13:3, pages 15-31.
Crossref
Crossref
Oluwadamilola Onasanya, Geetha Iyer, Eleanor Lucas, Dora Lin, Sonal Singh & G Caleb Alexander. (2016) Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews. The Lancet Diabetes & Endocrinology 4:11, pages 943-956.
Crossref
Crossref
Mario Maggi, Frederick C.W. Wu, Thomas H. Jones, Graham Jackson, Hermann M. Behre, Geoffrey Hackett, Antonio Martin-Morales, Giancarlo Balercia, Adrian S. Dobs, Stefan T.E. Arver, Marcello Maggio, Glenn R. Cunningham, Andrea M. Isidori, Richard Quinton, Olivia A. Wheaton, Flora S. Siami & Raymond C. Rosen. (2016) Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME). International Journal of Clinical Practice 70:10, pages 843-852.
Crossref
Crossref
Yi X. Chan, Matthew W. Knuiman, Joseph Hung, Mark L. Divitini, John P. Beilby, David J. Handelsman, Jonathan Beilin, Brendan McQuillan & Bu B. Yeap. (2016) Neutral associations of testosterone, dihydrotestosterone and estradiol with fatal and non-fatal cardiovascular events, and mortality in men aged 17-97 years. Clinical Endocrinology 85:4, pages 575-582.
Crossref
Crossref
Bu B Yeap, Mathis Grossmann, Robert I McLachlan, David J Handelsman, Gary A Wittert, Ann J Conway, Bronwyn GA Stuckey, Douglas W Lording, Carolyn A Allan, Jeffrey D Zajac & Henry G Burger. (2016) Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations. Medical Journal of Australia 205:5, pages 228-231.
Crossref
Crossref
A. A. Yassin, J. Nettleship, Y. Almehmadi, M. Salman & F. Saad. (2016) Effects of continuous long-term testosterone therapy (TTh) on anthropometric, endocrine and metabolic parameters for up to 10 years in 115 hypogonadal elderly men: real-life experience from an observational registry study. Andrologia 48:7, pages 793-799.
Crossref
Crossref
G. Corona, V. A. Giagulli, E. Maseroli, L. Vignozzi, A. Aversa, M. Zitzmann, F. Saad, E. Mannucci & M. Maggi. (2016) Testosterone supplementation and body composition: results from a meta-analysis of observational studies. Journal of Endocrinological Investigation 39:9, pages 967-981.
Crossref
Crossref
Mohit Khera, Gregory A. Broderick, Culley C. CarsonIIIIII, Adrian S. Dobs, Martha M. Faraday, Irwin Goldstein, Lawrence S. Hakim, Wayne J.G. Hellstrom, Ravi Kacker, Tobias S. Köhler, Jesse N. Mills, Martin Miner, Hossein Sadeghi-Nejad, Allen D. Seftel, Ira D. Sharlip, Stephen J. Winters & Arthur L. Burnett. (2016) Adult-Onset Hypogonadism. Mayo Clinic Proceedings 91:7, pages 908-926.
Crossref
Crossref
Abraham Morgentaler, Michael Zitzmann, Abdulmaged M. Traish, Anthony W. Fox, T. Hugh Jones, Mario Maggi, Stefan Arver, Antonio Aversa, Juliana C.N. Chan, Adrian S. Dobs, Geoffrey I. Hackett, Wayne J. Hellstrom, Peter Lim, Bruno Lunenfeld, George Mskhalaya, Claude C. Schulman & Luiz O. Torres. (2016) Fundamental Concepts Regarding Testosterone Deficiency and Treatment. Mayo Clinic Proceedings 91:7, pages 881-896.
Crossref
Crossref
G. Rastrelli, L. Giovannini, A. E. Calogero, D. Gianfrilli, E. Serra, A. Pizzocaro, V. A. Giagulli, G. Motta, G. Vancieri, A. Sperandio, S. Andò, R. Selice, G. Luca, F. Cocchiara, D. Canale & M. Maggi. (2016) Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry. Journal of Endocrinological Investigation 39:6, pages 695-708.
Crossref
Crossref
Ardalan E. Ahmad, Matthew Bruha & Charles Welliver. (2016) Age-Related Testosterone Decline: Whom Do We Treat and Why?. Current Sexual Health Reports 8:2, pages 97-105.
Crossref
Crossref
Monique S. Tanna, Arthur Schwartzbard, Jeffery S. Berger, James Underberg, Eugenia Gianos & Howard S. Weintraub. (2016) Management of Hypogonadism in Cardiovascular Patients. Urologic Clinics of North America 43:2, pages 247-260.
Crossref
Crossref
C Mary Schooling. (2016) Could androgens be relevant to partly explain why men have lower life expectancy than women?. Journal of Epidemiology and Community Health 70:4, pages 324-328.
Crossref
Crossref
Mohit Khera. (2016) Testosterone is Protective against Cardiac Disease: Pro. The Journal of Urology 195:4, pages 831-832.
Crossref
Crossref
John E. Morley. (2015) Pharmacologic Options for the Treatment of Sarcopenia. Calcified Tissue International 98:4, pages 319-333.
Crossref
Crossref
Mohit Khera. (2016) Male hormones and men's quality of life. Current Opinion in Urology 26:2, pages 152-157.
Crossref
Crossref
Moshrik Abd alamir, Susan S. Ellenberg, Ronald S. Swerdloff, Nanette K. Wenger, Emile R. Mohler, Cora E. Lewis, Elizabeth Barrett-Conner, Rine Nakanishi, Sirous Darabian, Anas Alani, Suguru Matsumoto, Negin Nezarat, Peter J. Snyder & Matthew J. Budoff. (2016) The Cardiovascular Trial of the Testosterone Trials. Coronary Artery Disease 27:2, pages 95-103.
Crossref
Crossref
Gerald Brock, Darell Heiselman, Mario Maggi, Sae Woong Kim, José M. Rodríguez Vallejo, Hermann M. Behre, John McGettigan, Sherie A. Dowsett, Risa P. Hayes, Jack Knorr, Xiao Ni & Kraig Kinchen. (2016) Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo Controlled Study. Journal of Urology 195:3, pages 699-705.
Crossref
Crossref
Andrea M. Isidori, Tami S. Rowen & Alan W. Shindel. (2016) Current Literature Review. Sexual Medicine 4:1, pages e2-e6.
Crossref
Crossref
Christina Wang, Mario P. R. Festin & Ronald S. Swerdloff. (2016) Male Hormonal Contraception: Where Are We Now?. Current Obstetrics and Gynecology Reports 5:1, pages 38-47.
Crossref
Crossref
Peter J. SnyderShalender BhasinGlenn R. CunninghamAlvin M. MatsumotoAlisa J. Stephens-ShieldsJane A. CauleyThomas M. GillElizabeth Barrett-ConnorRonald S. SwerdloffChristina WangKristine E. EnsrudCora E. LewisJohn T. FarrarDavid CellaRaymond C. RosenMarco PahorJill P. CrandallMark E. MolitchDenise CifelliDarlene DougarLaura FluhartySusan M. ResnickThomas W. StorerStephen AntonShehzad BasariaSusan J. DiemXiaoling HouEmile R. MohlerIIIIIIJ. Kellogg ParsonsNanette K. WengerBret ZeldowJ. Richard LandisSusan S. Ellenberg. (2016) Effects of Testosterone Treatment in Older Men. New England Journal of Medicine 374:7, pages 611-624.
Crossref
Crossref
Aleš Horák. (2016) Testosteron replacement therapy and cardiovascular risk. Urologie pro praxi 17:1, pages 23-26.
Crossref
Crossref
Robert A. Kloner, Culley CarsonIIIIII, Adrian Dobs, Stephen Kopecky & Emile R. MohlerIIIIII. (2016) Testosterone and Cardiovascular Disease. Journal of the American College of Cardiology 67:5, pages 545-557.
Crossref
Crossref
G. I. Hackett. (2015) Testosterone Replacement Therapy and Mortality in Older Men. Drug Safety 39:2, pages 117-130.
Crossref
Crossref
Emily J. Gianatti, Rudolf Hoermann, Que Lam, Philippe Dupuis, Jeffrey D. Zajac & Mathis Grossmann. (2016) Effect of testosterone treatment on cardiac biomarkers in a randomized controlled trial of men with type 2 diabetes. Clinical Endocrinology 84:1, pages 55-62.
Crossref
Crossref
Bu B. Yeap. 2016. Biomarkers in Cardiovascular Disease. Biomarkers in Cardiovascular Disease
425
447
.
D. Varwig-Janßen & F. Ochsendorf. (2015) Der „dicke“ und der „alte“ Patient in der dermatologischen PraxisThe “obese” and “old” male patient in dermatological practice. Der Hautarzt 66:12, pages 898-906.
Crossref
Crossref
Maria Cristina Meriggiola & Giulia Gava. (2015) Endocrine care of transpeople part I. A review of cross‐sex hormonal treatments, outcomes and adverse effects in transmen. Clinical Endocrinology 83:5, pages 597-606.
Crossref
Crossref
Antonio Aversa & Abraham Morgentaler. (2015) The practical management of testosterone deficiency in men. Nature Reviews Urology 12:11, pages 641-650.
Crossref
Crossref
Giuseppe M. C. Rosano, Cristiana Vitale & Massimo Fini. (2015) Testosterone in men with hypogonadism and high cardiovascular risk, Pros. Endocrine 50:2, pages 320-325.
Crossref
Crossref
Rishi Sharma, Olurinde A. Oni, Kamal Gupta, Guoqing Chen, Mukut Sharma, Buddhadeb Dawn, Ram Sharma, Deepak Parashara, Virginia J. Savin, John A. Ambrose & Rajat S. Barua. (2015) Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men. European Heart Journal 36:40, pages 2706-2715.
Crossref
Crossref
Christopher D. Gaffney, Matthew J. Pagano, Adriana P. Kuker, Doron S. Stember & Peter J. Stahl. (2015) Osteoporosis and Low Bone Mineral Density in Men with Testosterone Deficiency Syndrome. Sexual Medicine Reviews 3:4, pages 298-315.
Crossref
Crossref
Neil Goodman, Andre Guay, Paresh Dandona, Sandeep Dhindsa, Charles Faiman & Glenn R. Cunningham. (2015) American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of Testosterone and Cardiovascular Risk. Endocrine Practice 21:9, pages 1066-1073.
Crossref
Crossref
Yonah Krakowsky & Ethan D. Grober. (2015) Defining the best candidates for testosterone replacement?. Cardiovascular Endocrinology 4:3, pages 77-82.
Crossref
Crossref
Geoff I. Hackett. (2015) Cardiometabolic effects of testosterone in older men. Cardiovascular Endocrinology 4:3, pages 108-113.
Crossref
Crossref
Ludwig Schaaf. (2015) Testosteron schützt das DiabetikerherzMetabolic syndrome and hypogonadism. Testosteron may protect the heart in type 2 diabetes mellitus. MMW - Fortschritte der Medizin 157:15, pages 65-68.
Crossref
Crossref
Displaying 200 of 227 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list